A Study of LUMIGAN® RC in the Clinical Setting
NCT01833741
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1137
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma, Primary Open Angle
Ocular Hypertension
Interventions
DRUG:
Bimatoprost 0.01%
Sponsor
Allergan